Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Miaoshou Doctor

Explore full profile

Online drugs wholesales company providing expert advise

Fengtai District, ChinaFounded 2015Biotech & Life Sciences
Valuation $1–2.5B Last recorded · 2026
Revenue $500M–1B Latest reported FY
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Miaoshou Doctor and the history behind them.

At a glance

Founded
2015
Headquarters
Fengtai District, China
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tier

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

21 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later21 investors entered at this stage

  • Qiming Venture Partners
  • Gopher Asset Management
  • Index Capital
  • EFund
  • OrbiMed
  • Hel Ved Capital
  • QC Capital
  • CITIC Securities
  • UOB Venture
  • Investors
  • Tencent
  • China Capital Investment Group
  • Index Ventures
  • BOC International
  • INCE Capital
  • B Capital
  • SpringHill Management
  • Kunling Capital
  • ABI Capital
  • HSG
  • Starquest Capital

Ownership

Share of equity by holder

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

29.8% Founders

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Fengtai District HQ
Book a demo for the full country breakdown
Web traffic by country
470K monthly visits
across markets
🇨🇳 China99.9%
🇺🇸 United States0.8%
🇹🇼 Taiwan0.1%
🇲🇾 Malaysia0.1%
🇭🇰 Hong Kong0.1%
Top 5 markets shown

Patents

Estimated portfolio value
$711k

36 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Miaoshou Doctor was the backer or acquirer, 2018–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across Miaoshou Doctor's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Miaoshou Doctor deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Miaoshou Doctor's portfolio, mapped.

        Stage
        Period
        5 of 5 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Miaoshou Doctor on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Miaoshou Doctor on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles